A genetic report is one of the few documents that can answer a question and breed six new ones before lunch.
People see a gene name on a lab result and assume the mystery has been solved. There it is: the cause, the forecast, the treatment plan and the family’s future compressed into a few clinical lines. The paperwork looks authoritative. The uncertainty gets treated like fine print nobody needs to read.
What is actually happening is more useful—and less cinematic. My testing found disease-associated changes in PRKN, a gene linked to young-onset Parkinson’s. That can sharpen the biological explanation for why Parkinson’s entered my life so early. It does not turn the report into a crystal ball.
PRKN helps make parkin, a protein involved in how cells manage damaged mitochondria. Researchers study that pathway because it may reveal targets for future treatments. That is real science. It is not the same as saying one result can predict every symptom, the exact speed of progression or which treatment will work forever.
After 35 years with Parkinson’s, I have already lived more history than a genetic report can summarize. The result adds an important piece. It does not retroactively make every medical decision obvious, and it does not reduce decades of treatment response, setbacks, adaptation and plain dumb luck to one neat molecular sentence.
A gene can explain part of how Parkinson’s arrived without writing the rest of my life.
The cost of pretending otherwise lands fast. The person becomes the mutation. Relatives hear ‘genetic’ and start mentally diagnosing themselves. A promising research pathway gets translated online into a cure announcement before the laboratory has finished clearing its throat. Then uncertainty sounds like incompetence instead of what it is: the honest boundary of current knowledge.
Determinism also damages research. One person’s genetic result and unusual treatment response can generate a serious hypothesis. It cannot, by itself, prove a mechanism or prescribe care for everyone who shares the gene. A compelling case is where investigation begins, not where peer review goes to die.
What needs to change is the conversation around the result. Ask which variants were found, how they were classified and what inheritance pattern may apply. Ask what the finding explains, what it does not explain and whether the interpretation could change as evidence improves. Bring a qualified genetic counselor into the discussion before turning family risk into a group panic attack.
Clinicians and researchers should speak with precision. Families deserve context, not a forwarded screenshot and an amateur prophecy. People with Parkinson’s deserve to be more than a sample with shoes on.
The result matters. So does the uncertainty around it. I can respect the biology without surrendering my biography to it.
TODAY’S DEFIANT TRUTH:
The genetic test found evidence. It did not find my future.
Evidence is not destiny. Read the whole result, respect what remains unknown and never confuse a gene with a finished life.
Live Defiantly. — Richie Pikunis